Related Experiment Videos
Altered sirtuin expression is associated with node-positive breast cancer
N Ashraf1, S Zino, A Macintyre
1Division of Cancer Sciences and Molecular Pathology, Department of Surgery, University of Glasgow, Western Infirmary Glasgow, 44 Church Street, Glasgow G11 6NT, UK.
British Journal of Cancer
|September 28, 2006
Summary
Sirtuin gene expression differs between normal and malignant breast tissues. Elevated SIRT3 and SIRT7 levels indicate more advanced breast cancer, suggesting diagnostic and therapeutic potential.
Area of Science:
- Molecular Biology
- Oncology
- Aging Research
Background:
- Sirtuins are key regulators of cellular processes, including aging.
- Their role in cancer, particularly breast cancer progression, remains incompletely understood.
- Differential sirtuin expression is observed across various cancers.
Purpose of the Study:
- To investigate the correlation between sirtuin gene expression and breast cancer progression.
- To compare sirtuin expression in normal versus malignant breast tissue.
- To assess sirtuin expression in relation to primary cell aging.
Main Methods:
- Real-time polymerase chain reaction (PCR) was employed to quantify sirtuin gene expression.
- Sirtuin expression was analyzed in normal breast biopsies and matched breast cancer biopsies.
- Expression levels were correlated with primary cell aging and lymph node status.
Main Results:
- SIRT7 expression was significantly elevated in breast cancer tissues compared to nonmalignant tissues (P<0.0001).
- Higher SIRT3 and SIRT7 transcription levels were associated with node-positive breast cancer (P<0.05 and P<0.0001, respectively).
- Differential expression patterns of sirtuins were observed between nonmalignant and malignant breast samples.
Conclusions:
- Sirtuin expression profiles differ significantly between nonmalignant and malignant breast tissues.
- Elevated SIRT3 and SIRT7 expression may serve as biomarkers for advanced breast cancer.
- These findings highlight potential diagnostic and therapeutic implications of sirtuins in breast cancer.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...